Artykuły prasowe

Melanoma treatment in review

2018 Jun 7, Beatriz Domingues, José Manuel Lopes, Paula Soares, Helena Pópulo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995433/

ASCO Congress 2018: melanoma treatment

2018 Nov 20, Erika Richtig

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280769/

Progress in adjuvant treatment of melanoma patients

Piotr Rutkowski, Wojciech M. Wysocki, Tomasz Świtaj, Arkadiusz Jeziorski

https://journals.viamedica.pl/nowotwory_journal
_of_oncology/article/view/61901

The age of enlightenment in melanoma immunotherapy

22 August 2018, Mark R. Albertini

https://jitc.biomedcentral.com/articles/10.1186/s40425-018-0397-8

Metastatic melanoma – a review of current and future treatment options. Acta Derm Venereol.

2015 Apr. Maverakis E1, Cornelius LA, Bowen GM, Phan T, Patel FB, Fitzmaurice S, He Y, Burrall B, Duong C, Kloxin AM, Sultani H, Wilken R, Martinez SR, Patel F

http://www.ncbi.nlm.nih.gov/pubmed/25520039

The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma. Clin Ther.

2015 Apr. Mahoney KM1, Freeman GJ2, McDermott DF3.

http://www.ncbi.nlm.nih.gov/pubmed/25823918

Risk of subsequent melanoma after melanoma in situ and invasive melanoma: A population-based study from 1973 to 2011.

Pomerantz H1, Huang D2, Weinstock MA3. J Am Acad Dermatol. 2015 May

http://www.ncbi.nlm.nih.gov/pubmed

Diagnosis and management of lentigo maligna: a review. Drugs Context.

2015 May 29 Kasprzak JM1, Xu YG1.

http://www.ncbi.nlm.nih.gov/pubmed/26082796